Optimal IFN therapy for 40-year-old patients with severe HCV-1b infection

被引：1
|
作者：
Moriguchi, H [1 ]
Kobayashi, M
Chung, RT
Sato, C
机构：
[1] Univ Tokyo, Div Adv Med Technol & Intellectual Property Polic, Res Ctr Adv Sci & Technol, Tokyo 1130033, Japan
[2] Crecon Res & Consulting Inc, Hlth Econ Res Grp, Tokyo, Japan
[3] Massachusetts Gen Hosp, Gastrointestinal Unit, Boston, MA 02114 USA
[4] Harvard Univ, Sch Med, Boston, MA 02115 USA
[5] Tokyo Med & Dent Univ, Grad Sch, Dept Analyt Hlth Sci, Tokyo 1138549, Japan
来源：
GASTROENTEROLOGY | 2003年 / 124卷 / 04期
关键词：
D O I：
10.1053/gast.2003.50200
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：1166 / 1167
页数：2
相关论文
共 50 条
  • [41] Bilateral Central Retinal Vein Occlusion in a 40-Year-Old Man with Severe Coronavirus Disease 2019 (COVID-19) Pneumonia
    Gaba, Waqar Haider
    Ahmed, Deena
    Al Nuaimi, Rawdha Khateefa
    Al Dhahani, Aishah Ali
    Eatmadi, Habibullah
    [J]. AMERICAN JOURNAL OF CASE REPORTS, 2020, 21 : e927691 - 1
  • [42] Mutation in the NS5A Region of Chinese HCV-1b Isolates and Its Correlation with Efficacy of Interferon Alpha Therapy
    Zhang Yongxiang(张永祥) Sun Nanxiong(孙南雄)\ Huang Zuhu(黄祖瑚) Han Yaping(韩亚萍)\ Liu Ting(刘 婷) Research Laboratory of Infectious Diseases
    [J]. The Journal of Biomedical Research, 2000, (01) : 1 - 6
  • [43] Unusual amino acid heterogeneity within the HCV-1b NS5a region for patients with hepatocellular carcinoma
    Giménez-Barcons, M
    Forns, X
    Suárez, Y
    Sánchez-Fueyo, A
    Ampurdanès, A
    Barrera, JM
    Llovet, JM
    Bruix, J
    Rodés, J
    Sánchez-Tapias, JM
    Sáiz, JC
    [J]. JOURNAL OF HEPATOLOGY, 2000, 32 : 85 - 85
  • [44] Is investigation of HCV genomic heterogeneity a tool for predicting response to interferon therapy in patients with HCV1B chronic infection?.
    Squadrito, G
    Raffa, G
    Restuccia, T
    Pollicino, T
    Raimondo, G
    [J]. HEPATOLOGY, 2001, 34 (04) : 561A - 561A
  • [45] IFN-free therapy is associated with restoration of type I IFN response in HIV-1 patients with acute HCV infection who achieve SVR
    Carlton-Smith, C.
    Holmes, J. A.
    Naggie, S.
    Lidofsky, A.
    Lauer, G. M.
    Kim, A. Y.
    Chung, R. T.
    [J]. JOURNAL OF VIRAL HEPATITIS, 2018, 25 (05) : 465 - 472
  • [46] Is there still a role for PEG IFN plus RBV therapy in patients with HCV genotype 1?
    Serfaty, Lawrence
    [J]. LIVER INTERNATIONAL, 2014, 34 : 11 - 12
  • [47] Rapid viral clearance with IFN-α 2b induction therapy and ribavirin for chronic HCV infection
    Bjoro, K
    Bell, H
    Hellum, KB
    Myrvang, B
    Skaug, K
    [J]. JOURNAL OF HEPATOLOGY, 2000, 32 : 38 - 38
  • [48] Study of the genetic heterogeneity of the NS5A region of the HCV-1b genome and evolution under interferon alfa therapy.
    Germanidis, G
    Pellerin, M
    Bastie, A
    Stuyver, L
    Duverlie, G
    Darthuy, F
    Remire, J
    Duval, J
    Dhumeaux, D
    Pawlotsky, JM
    [J]. HEPATOLOGY, 1996, 24 (04) : 551 - 551
  • [49] Feasibility and Benefit of Cognitive Behavioural Therapy for Psychosis via Teleconsultation in Indonesia: A Case Study of a 40-Year-Old Schizoaffective Disorder Patient
    Sutjiono, Bianca
    Ahmad, Shafira Fawzia
    Jaya, Edo S.
    [J]. BEHAVIOUR CHANGE, 2023, 40 (03) : 155 - 168
  • [50] A 40-year-old woman with the rapid onset of flaccid paraplegia - Chronic Schistosoma mansoni infection, with involvement of the large intestine and spinal cord.
    Liu, LX
    Compton, CC
    Seltzer, S
    Jenkins, TD
    Ueki, K
    Cao, HY
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1996, 334 (06): : 382 - 389
12345